Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin - A randomized controlled trial / Blazing, Ma; de Lemos, Ja; White, Hd; Fox, Kaa; Verheugt, Fwa; Ardissino, D; Dibattiste, Pm; Palmisano, J; Bilheimer, Dw; Snapinn, Sa; Ramsey, Ke; Gardner, Lh; Hasselblad, V; Pfeffer, Ma; Lewis, Ef; Braunwald, E; Califf, Ra. - In: JAMA. - ISSN 0098-7484. - 292:1(2004), pp. 55-64. [10.1001/jama.292.1.55]

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin - A randomized controlled trial

Ardissino D;
2004-01-01

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin - A randomized controlled trial / Blazing, Ma; de Lemos, Ja; White, Hd; Fox, Kaa; Verheugt, Fwa; Ardissino, D; Dibattiste, Pm; Palmisano, J; Bilheimer, Dw; Snapinn, Sa; Ramsey, Ke; Gardner, Lh; Hasselblad, V; Pfeffer, Ma; Lewis, Ef; Braunwald, E; Califf, Ra. - In: JAMA. - ISSN 0098-7484. - 292:1(2004), pp. 55-64. [10.1001/jama.292.1.55]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2883526
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 181
social impact